Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Change in Accured Expenses (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Change in Accured Expenses data on record, last reported at $306000.0 in Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 130.06% year-over-year to $306000.0; the TTM value through Dec 2025 reached -$3.3 million, up 56.86%, while the annual FY2025 figure was -$3.3 million, 56.86% up from the prior year.
  • Change in Accured Expenses reached $306000.0 in Q4 2025 per QTTB's latest filing, up from -$511000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $6.6 million in Q2 2022 and bottomed at -$5.0 million in Q1 2022.
  • Average Change in Accured Expenses over 5 years is -$96250.0, with a median of -$700000.0 recorded in 2025.
  • The widest YoY moves for Change in Accured Expenses: up 341.8% in 2021, down 748.6% in 2021.
  • A 5-year view of Change in Accured Expenses shows it stood at $1.3 million in 2021, then soared by 36.94% to $1.7 million in 2022, then skyrocketed by 34.42% to $2.3 million in 2023, then tumbled by 143.37% to -$1.0 million in 2024, then skyrocketed by 130.06% to $306000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $306000.0 in Q4 2025, -$511000.0 in Q3 2025, and -$889000.0 in Q2 2025.